Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse model.

Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse model.

Item
http://www.wikidata.org/entity/Q39694901
Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?A differential role for CD248 (Endosialin) in PDGF-mediated skeletal muscle angiogenesisGonadotoxic Effects of Nilotinib in Chronic Myeloid Leukemia Treatment Dose in a Mouse ModelCisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatinClinical review: kinase inhibitors: adverse effects related to the endocrine system.Smooth muscle hyperplasia due to loss of smooth muscle α-actin is driven by activation of focal adhesion kinase, altered p53 localization and increased levels of platelet-derived growth factor receptor-β.Pediatric chronic myeloid leukemia is a unique disease that requires a different approachEffects of chemotherapy and radiotherapy on spermatogenesis in humans.Targeted therapy with kinase inhibitors in aggressive endocrine tumors.Adverse effects of common medications on male fertility.The Effects of Imatinib Mesylate on Cellular Viability, Platelet Derived Growth Factor and Stem Cell Factor in Mouse Testicular Normal Leydig Cells.Imatinib alters cell viability but not growth factors levels in TM4 Sertoli cells.Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy.Vitrification of embryos and oocytes for fertility preservation in cancer patients.Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib.Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years.Pregnancy: part of life in chronic myelogenous leukemia.
P2860

Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse model.

Item
http://www.wikidata.org/entity/Q39694901
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Imatinib mesylate at therapeut ...... is in a leukaemic mouse model.
@en
Imatinib mesylate at therapeut ...... is in a leukaemic mouse model.
@nl
type
label
Imatinib mesylate at therapeut ...... is in a leukaemic mouse model.
@en
Imatinib mesylate at therapeut ...... is in a leukaemic mouse model.
@nl
prefLabel
Imatinib mesylate at therapeut ...... is in a leukaemic mouse model.
@en
Imatinib mesylate at therapeut ...... is in a leukaemic mouse model.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Imatinib mesylate at therapeut ...... is in a leukaemic mouse model.
@en
P2093
P304
P31
P356
10.1016/J.LEUKRES.2011.09.025
P433
P478
P577
P698
P921